INAB
$1.91
Market ClosedAs of Mar 17, 8:00 PM UTC
IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and autoimmune diseases.
Intraday
Custom Range:to
No data available for this range. Intraday data may be limited by the exchange.
Recent News
No recent news found.